Habit Awareness Device for Treatment of Onychophagia

Sponsor
Weill Medical College of Cornell University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06111729
Collaborator
(none)
10
1
1
7
1.4

Study Details

Study Description

Brief Summary

This clinical trial wants to find out if using a special bracelet that vibrates gently whenever someone with a nail-biting problem bites their nails can help them stop. The investigators are looking at adults who bite their nails a lot. If this bracelet works, it could make nail-biters bite their nails less and have a better life.

The main question the investigators are trying to answer is: "Does the gentle vibration from the bracelet make people bite their nails less?"

The investigators will give participants a bracelet that vibrates when it senses nail-biting for 12 weeks. Participants will need to download an app that connects to the bracelet. This app will help the investigators keep track of how often participants get these vibration signals and see if nail-biting decreases while using the bracelet.

Condition or Disease Intervention/Treatment Phase
  • Device: HabitAware group
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Habit Awareness Device for Treatment of Onychophagia
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
May 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: HabitAware Participants

Patients will be asked to wear the HabitAwareness bracelet for 12 weeks. The bracelet provides the attention stimulus of gentle vibration when the motion of nail biting is sensed.

Device: HabitAware group
A device that provides gentle vibration when the motion of nail biting is sensed will be provided to all participants. Participants will use an app that connects to the device to track the frequency of their nail biting over the study period.

Outcome Measures

Primary Outcome Measures

  1. Mean Change in Nail Biting Behavior as Measured by Number of Patient Reported Vibrations a Day [baseline; 4 weeks; 8 weeks; 12 weeks]

Secondary Outcome Measures

  1. Change in nail length in millimeters [Monthly for 3 months]

  2. Change in nail health as measured by Malone-Massler Scale For Nail Biting [baseline; 3 months]

    The lowest score is 0 meaning nails not bitten, free margin intact; the highest score is 3+ meaniing nails are severely bitten, fingernails bitten beyond free edge; nail margin below soft tissue border

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 95 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Patients diagnosed with onychophagia

  2. Must understand and voluntarily sign an informed consent form

  3. Must be aged 18-95 years at the time of consent

  4. Must be able to adhere to the study visit schedule and other protocol requirements

Exclusion Criteria:
  1. Subject is unable to provide written informed consent for any reason.

  2. Subject is sensitive or allergic to any of the elements included in this study.

  3. Subject is unable to complete the required pain dairy.

  4. Subject is pregnant, planning pregnancy, or nursing.

  5. Subject does not have a compatible personal device with either IOS 13.0 or greater or Android version 6.0 or greater.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Weill Cornell Department of Dermatology New York New York United States 10022

Sponsors and Collaborators

  • Weill Medical College of Cornell University

Investigators

  • Principal Investigator: Shari Lipner, MD, PhD, Professor of Clinical Dermatology

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT06111729
Other Study ID Numbers:
  • 22-12025533
First Posted:
Nov 1, 2023
Last Update Posted:
Nov 1, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes

Study Results

No Results Posted as of Nov 1, 2023